Venture capital in Chile jumps 160% in 2025 and approaches its best year ever

La TerceraIndependent🔒CenterFactual 95Objective 852 days ago

The article reports that venture capital investment in Chilean startups reached $813 million in 2025, according to the 2026 Impact Report by the Chilean Association of Venture Capital (ACVC). This represents a more than 160% increase compared to $311 million in 2024 and brings Chile close to its historical high of $898 million in 2023. The surge is attributed partly to a $308 million round closed by Runway, a U.S.-based AI startup co-founded by two Chileans. Even excluding this large investment, Chile saw $505 million invested in 2025, marking a 62% rise over 2024. Magdalena Guzmán, ACVC’s Executive Director, notes that globally, venture capital has rebounded strongly since 2022, with many Chilean funds now deploying their committed capital after years of caution. The report highlights a shift in investor strategy, with fewer but larger rounds—274 in 2025, down 21% from 2024, but with an average size of $2.9 million, up 231%. Globally, venture capital funding reached $469 billion in 2025, the highest since 2022, with AI startups capturing nearly half of all investments.

Bias read (Center): While the article discusses economic trends related to venture capital, which could be considered part of broader economic policy, the focus remains on market performance and industry dynamics rather than direct political advocacy or partisan framing. The tone is neutral, presenting data and expert-

Why these scores (Factual 95 · Objective 85): This article provides detailed statistics from the ACVC Impact Report 2026, including figures and percentages, supporting its claims about venture capital growth. It presents information objectively, though it highlights the success of Runway with some promotional language, slightly affecting object

La TerceraIndependent🔒CenterFactual 88Objective 827 days ago

The Association of Pharmaceutical Laboratories (Asilfa), celebrating its 40th anniversary in 2026, represents 15 members, six of which operate production facilities in Chile. The group produces 60% of its total output domestically and holds 27.5% of the pharmaceutical market in Chile. Patricio Huenchuñir, Asilfa’s executive vice president, highlights the industry’s strong position but emphasizes the need for support to strengthen it further. He notes challenges such as demographic changes, including an aging population, which require increased drug production capacity. Asilfa has engaged with the Ministry of Health to address concerns like the upcoming renewal of the Public Health Institute’s (ISP) certification by the World Health Organization (WHO) and delays in medication registration processes, which currently take 20–24 months instead of the mandated 6 months.

Bias read (Center): The article presents information from industry representatives and outlines their interactions with the government regarding regulatory and developmental issues. It does not exhibit overtly biased language, one-sided sourcing, or editorializing. The content focuses on industry challenges and goals,

Why these scores (Factual 88 · Objective 82): The article cites Asilfa’s 40th anniversary and mentions specific percentages and events like Alifar meetings, providing factual context. While it includes quotes from officials, it leans slightly toward promoting Chile’s potential as an exporter, which affects objectivity.

BioBioChileIndependentCenterFactual 65Objective 704 days ago

The main article discusses predictions by Chile's large business sector regarding the country's economic growth for 2026. According to these forecasts, Chile's GDP growth is expected to be no more than 1.5% in the coming year. This projection suggests a slowdown compared to previous years and reflects concerns among major businesses about the economic outlook. The statement 'el año está relativamente jugado' implies that the outcome for 2026 is already largely determined or predictable based on current trends. These expectations could influence investment decisions and policy-making in the country.

Bias read (Center): The article presents economic projections from the business community without overtly favoring any particular political stance. It reports on expectations rather than advocating for specific policies or criticizing political actors directly. The framing remains neutral, focusing on economic data and

Why these scores (Factual 65 · Objective 70): The article reports on business expectations for Chile's economic growth in 2026 but lacks specific data or sources to back up the claim of 1.5% growth. It aligns with the general consensus among articles about economic challenges, but the lack of detailed evidence reduces its factuality score. The